Cargando…

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants

BACKGROUND: Lysergic acid diethylamide (LSD) is currently being investigated in psychedelic-assisted therapy. LSD has a long duration of acute action of 8–11 hours. It produces its acute psychedelic effects via stimulation of the serotonin 5-hydroxytryptamine-2A (HT(2A)) receptor. Administration of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Becker, Anna M, Klaiber, Aaron, Holze, Friederike, Istampoulouoglou, Ioanna, Duthaler, Urs, Varghese, Nimmy, Eckert, Anne, Liechti, Matthias E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926053/ https://www.ncbi.nlm.nih.gov/pubmed/36342343 http://dx.doi.org/10.1093/ijnp/pyac075

Ejemplares similares

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants
por: Straumann, Isabelle, et al.
Publicado: (2023)

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
por: Becker, Anna M., et al.
Publicado: (2021)

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
por: Ley, Laura, et al.
Publicado: (2023)

Role of the 5-HT(2A) Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
por: Holze, Friederike, et al.
Publicado: (2021)

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
por: Vogt, Severin B., et al.
Publicado: (2023)

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2020)

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2022)

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2019)

Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects
por: Vizeli, Patrick, et al.
Publicado: (2022)

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
por: Müller, Felix, et al.
Publicado: (2022)

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2020)

Safety pharmacology of acute LSD administration in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2021)

OR17-01 Novel Provocation Test With MDMA (‘Ecstasy’) Reveals Oxytocin Deficiency As A New Pituitary Entity In Patients With Central Diabetes Insipidus - A Randomized Placebo-Controlled Trial
por: Atila, Cihan, et al.
Publicado: (2023)

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
por: Vizeli, Patrick, et al.
Publicado: (2021)

Effects of ketanserin on experimental colitis in mice and macrophage function
por: XIAO, JUNHUA, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects
por: Müller, Felix, et al.
Publicado: (2020)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
por: Bedford, Peter, et al.
Publicado: (2023)

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
por: Maqueda, Ana Elda, et al.
Publicado: (2016)

Ketanserin as potential additive drug to improve V/Q mismatch in COVID-19?
por: Kuindersma, M., et al.
Publicado: (2020)

Modern Clinical Research on LSD
por: Liechti, Matthias E
Publicado: (2017)

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial
por: Yanakieva, Steliana, et al.
Publicado: (2018)

Effect of combination of ketanserin and escitalopram on behavioral anomalies after olfactory bulbectomy: Prediction of quick onset of antidepressant action
por: Pandey, Dilip K., et al.
Publicado: (2014)

Long-lasting subjective effects of LSD in normal subjects
por: Schmid, Yasmin, et al.
Publicado: (2017)

Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study
por: Sharpley, Ann L., et al.
Publicado: (2016)

Accumulation of myeloid lineage cells is mapping out liver fibrosis post injury: a targetable lesion using Ketanserin
por: Amini-Nik, Saeid, et al.
Publicado: (2018)

Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
por: Dolder, Patrick C., et al.
Publicado: (2015)

Psyllium Supplementation in Adolescents Improves Fat Distribution & Lipid Profile: A Randomized, Participant-Blinded, Placebo-Controlled, Crossover Trial
por: de Bock, Martin, et al.
Publicado: (2012)

Ondansetron in dogs with nausea associated with vestibular disease: A double‐blinded, randomized placebo‐controlled crossover study
por: Henze, Lea, et al.
Publicado: (2022)

Alterations of consciousness and mystical-type experiences after acute LSD in humans
por: Liechti, Matthias E., et al.
Publicado: (2016)

Ketanserin and Naftopidil Enhance the Potentiating Effect of Alpha-Methyl-Serotonin on the Neurally-Induced Contraction of Human Isolated Urinary Bladder Muscle Strips
por: Hattori, Tsuyoshi, et al.
Publicado: (2017)

Altered network hub connectivity after acute LSD administration
por: Müller, Felix, et al.
Publicado: (2018)

Dietary Mitophagy Enhancer: A Strategy for Healthy Brain Aging?
por: Varghese, Nimmy, et al.
Publicado: (2020)

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
por: Dolder, Patrick C, et al.
Publicado: (2016)

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants
por: Zomorodi, Katie, et al.
Publicado: (2020)

A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache
por: Ghose, Karabi, et al.
Publicado: (2002)

Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes
por: Kern, Charlotte, et al.
Publicado: (2023)

The beneficial effect of sulforaphane on platelet responsiveness during caloric load: a single-intake, double-blind, placebo-controlled, crossover trial in healthy participants
por: van Steenwijk, Hidde P., et al.
Publicado: (2023)

Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations
por: Müller, F., et al.
Publicado: (2017)

Is Skin-Touch Sham Needle Not Placebo? A Double-Blind Crossover Study on Pain Alleviation
por: Takayama, Miho, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h8miejeub6digahu5jnrn5ion2